2605003897
  • Open Access
  • Article

Pharmacological Investigation of the Active Fractions of Acacia crassicarpa Leaf Extract

  • As-Sazzad Mahmud *,   
  • Ariful Islam,   
  • Israt Jahan Meem,   
  • Md. Rabbi Hasan,   
  • Md. Mohiuddin Maruf,   
  • Tanvir Ahmed Anik,   
  • Mirja Mohammad Niaz Morshed

Received: 15 Jan 2026 | Revised: 05 May 2026 | Accepted: 12 May 2026 | Published: 22 May 2026

Abstract

Objective: This study explores the biological properties of Acacia crassicarpa A. Cunn. ex Benth, a member of the Fabaceae family. Known for its antimicrobial, anti-inflammatory, and antidiarrheal effects, this plant may be beneficial in treating skin infections, diarrhea, wounds, and ulcers. In this study, fractions of ethanolic leaf extracts were analyzed for their analgesic, anti-inflammatory, antipyretic, and acute toxicity effects. Methods: Analgesic, anti-inflammatory, antipyretic, and acute toxicity evaluations were conducted in vivo. The analgesic activity was assessed using the acetic acid-induced writhing method, while the anti-inflammatory effect was measured through the formaldehyde-induced paw edema method. Antipyretic activity was determined by monitoring changes in rectal temperature in mice. Acute oral toxicity was evaluated following the OECD (Organization for Economic Co-operation and Development) guidelines-423 (Fixed Dose Procedure). Results: In the analgesic test, the ethyl acetate fraction exhibited inhibition rates of 35.63% and 45.97% at doses of 250 mg/kg and 500 mg/kg, respectively. In the anti-inflammatory test, inhibition rates were recorded at 43.83% for 250 mg/kg and 58.9% for 500 mg/kg, with the higher dose showing a more significant anti-inflammatory effect. The antipyretic test confirmed that both 250 mg/kg and 500 mg/kg doses demonstrated antipyretic properties. Acute toxicity assessments revealed no toxic effects at doses up to 5000 mg/kg. Conclusion: The Acacia crassicarpa leaf extract demonstrated analgesic, anti-inflammatory, and antipyretic effects.

Graphical Abstract

References 

  • 1.

    Atanasov, A.G.; Zotchev, S.B.; Dirsch, V.M.; et al. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov. 2021, 20, 200–216.

  • 2.

    Truter, I. African traditional healers: Cultural and religious beliefs intertwined in a holistic way. S. Afr. Pharm. J. 2007, 74, 56–60.

  • 3.

    Gurib-Fakim, A. Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol. Asp. Med. 2006, 27, 1–93.

  • 4.

    Garcia-Alvarez, A.; Egan, B.; De Klein, S.; et al. Usage of plant food supplements across six European countries: Findings from the PlantLIBRA consumer survey. PLoS ONE 2014, 9, e92265.

  • 5.

    Ekor, M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014, 4, 177.

  • 6.

    Kumar, A.; P, N.; Kumar, M.; et al. Major phytochemicals: Recent advances in health benefits and extraction method. Molecules 2023, 28, 887.

  • 7.

    Ghlichloo, I.; Gerriets, V. Nonsteroidal anti-inflammatory drugs (NSAIDs); StatPearls Publishing: Treasure Island, FL, USA, 2019.

  • 8.

    Timbadiya, M.J.; Nishteswar, K.; Acharya, R.; et al. Experimental evaluation of antipyretic and analgesic activities of Amalakyadi Gana: An Ayurvedic formulation. AYU 2015, 36, 220–224.

  • 9.

    Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 1971, 231, 232–235.

  • 10.

    Wingfield, M.J.; Roux, J.; Wingfield, B.D. Insect pests and pathogens of Australian acacias grown as non‐natives–an experiment in biogeography with far‐reaching consequences. Divers. Distrib. 2011, 17, 968–977.

  • 11.

    Batiha, G.E.-S.; Akhtar, N.; Alsayegh, A.A.; et al. Bioactive compounds, pharmacological actions, and pharmacokinetics of genus Acacia. Molecules 2022, 27, 7340.

  • 12.

    Prayogo, Y.H.; Syafii, W.; Sari, R.K.; et al. Pharmacological activity and phytochemical profile of acacia heartwood extracts. Sci. Pharm. 2021, 89, 37.

  • 13.

    Prayogo, Y.H.; Batubara, I.; Wahyudi, S.T.; et al. Metabolite profile, antiproliferative, and antioxidant activity of Acacia auriculiformis and Acacia crassicarpa extracts. J. Saudi Chem. Soc. 2023, 27, 101742.

  • 14.

    Ali, M.A.; Lou, Y.; Hafeez, R.; et al. Functional analysis and genome mining reveal high potential of biocontrol and plant growth promotion in nodule-inhabiting bacteria within Paenibacillus polymyxa complex. Front. Microbiol. 2021, 11, 618601.

  • 15.

    Atiya, A.; Majrashi, T.; Akhtar, S.; et al. The value of Genus Acacia in arid and semi-arid environments for the treatment of chronic inflammatory diseases. Phytomed. Plus 2022, 2, 100315.

  • 16.

    Doan, T.Q.; Dinh, T.T.; Matsumoto, T.K.; et al. Chemical composition of essential oil of Acacia crassicarpa Benth. (Fabaceae) from Vietnam. Bull. Chem. Soc. Ethiop. 2025, 39, 1653–1660.

  • 17.

    Debnath, S.L.; Kundu, P.; Golder, M.; et al. Phytochemical Characterization and Evaluation of Pharmacological Activities of Leaves of a Mangrove Plant Species-Aegiceras corniculatum (L.): Doi. org/10.26538/tjnpr/v4i9. 4. Trop. J. Nat. Prod. Res. 2020, 4, 516–522.

  • 18.

    Subedi, N.K.; Rahman, S.A.; Akbar, M.A. Analgesic and antipyretic activities of methanol extract and its fraction from the root of Schoenoplectus grossus. Evid. ‐Based Complement. Altern. Med. 2016, 2016, 3820704.

  • 19.

    Malik, M.K.; Bhatt, P.; Singh, J.; et al. Preclinical safety assessment of chemically cross-linked modified mandua starch: Acute and sub-acute oral toxicity studies in Swiss albino mice. ACS Omega 2022, 7, 35506–35514.

  • 20.

    Jame, R.J.S. Phytochemical and pharmacological uses of Acacia nilotica—A review. Seeds 2018, 1, 15–21.

  • 21.

    Chaudhary, P.; Sharma, R.; Rawat, S.; et al. Antipyretic medicinal plants, phytocompounds, and green nanoparticles: An updated review. Curr. Pharm. Biotechnol. 2023, 24, 23–49.

  • 22.

    World Health Organization. WHO Expert Committee on Biological Standardization: Seventy-Eighth Report; World Health Organization: Geneva, Switzerland, 2024.

  • 23.

    Abdulkhaleq, L.; Assi, M.; Abdullah, R.; et al. The crucial roles of inflammatory mediators in inflammation: A review. Vet. World 2018, 11, 627.

  • 24.

    Vane, J.; Botting, R.M. Mechanism of action of anti-inflammatory drugs. Scand. J. Rheumatol. 1996, 25, 9–21.

  • 25.

    Liu, T.; Zhang, L.; Joo, D.; et al. NF-κB signaling in inflammation. Signal Transduct. Target. Ther. 2017, 2, 1–9.

  • 26.

    Flower, R.; Vane, J. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 1972, 240, 410–411.

  • 27.

    Gemeda, H.B.; Debella, A.; Endale, M.; et al. Acute and sub-acute toxicity of ethanol extracts of Hagenia abyssinica and Rumex abyssinicus flowers in Swiss albino mice. PLoS ONE 2025, 20, e0319464.

Share this article:
How to Cite
Mahmud, A.-S.; Islam, A.; Meem, I. J.; Hasan, Md. R.; Maruf, Md. M.; Anik, T. A.; Morshed, M. M. N. Pharmacological Investigation of the Active Fractions of Acacia crassicarpa Leaf Extract. Journal of Medicinal Natural Products 2026, 3 (2), 100010. https://doi.org/10.53941/jmnp.2026.100010.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2026 by the authors.